+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: not found

      Localized or systemic in vivo heat inactivation of human immunodeficiency virus (HIV): a mathematical analysis.

      Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association

      CD4 Lymphocyte Count, CD4-Positive T-Lymphocytes, virology, HIV Infections, therapy, HIV-1, physiology, Hot Temperature, Humans, Hyperthermia, Induced, Lymphocyte Depletion, Models, Biological

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Temperatures > or = 42 degrees C, maintained for > or = 25 min, inactivate approximately 25% of human immunodeficiency virus (HIV). HIV-infected T cells are more sensitive to heat than healthy lymphocytes, and susceptibility increases when the cells are presensitized by exposure to tumor necrosis factor. Thus, induction of a whole-body hyperthermia or hyperthermia specifically limited to tissues having a high viral load is a potential antiviral therapy for acquired immunodeficiency syndrome (AIDS). Accordingly, we incorporated therapeutic hyperthermia into an existing mathematical model that evaluates the interaction between HIV and CD4+ T cells. Given the assumptions and limitations of this model, the results indicate that a daily therapy lowering the population of actively infected cells by 40% or infectious virus by 40% would effectively reverse the depletion of T cells. In contrast, a daily decline of 20% of either actively infected cells or infectious virus would have a marginal effect. However, daily reduction by 20% of both actively infected cells and infectious virus could restore T-cell numbers, assuming that permanent damage had not been inflicted on the thymus. Since daily treatments would probably be excessively stressful, whole-body hyperthermia seems unlikely to be clinically useful. In contrast, heating directed specifically to areas of viral concentration may be effective and have a suitable risk/benefit ratio.

          Related collections

          Author and article information



          Comment on this article